Navigation Links
Engineered by RoosterBio Inc.: Universal Bioprocess Bags to Streamline Closed System Stem Cell Production
Date:12/8/2016

RoosterBio Inc announces the commercial launch of flexible packaging for their exceptionally efficient human mesenchymal stem/stromal cell (hMSC) expansion medium. This single use (“SU”) disposable bag system extends RoosterBio’s portfolio of bioprocess media products engineered to radically streamline culture processes, minimize processing time, significantly decrease production costs, and simplify the transition into scalable platforms for clinical and commercial adult stem cell manufacturing.

RoosterBio’s hMSC High Performance Media is now available in SU disposable bags engineered to be compatible with all major cell therapy/bioprocessing culture systems, including multi-layer vessels and suspension bioreactors. This flexible media packaging is made with best-in-class film technology and engineered with multiple weld-able or aseptic connection ports to enable rapid integration with scalable bioreactor technologies. With the introduction of this bagged media format, RoosterBio media systems are now instantly compatible with all major 2D and 3D cell culture systems. This system streamlines workflow by eliminating the need to transfer media from bottles to bags for closed system hMSC expansion, and reduces the custom engineering time required for transitioning to scalable cell culture systems.

Jon Rowley, CEO of RoosterBio stated: “The Stem Cell Therapy field is sorely lacking standards in single use disposables and bioreactor technology, slowing product development timelines throughout the industry. We are commercializing our best in class hMSC bioprocess media systems now in universal single-use bag configurations to further our mission of radically shortening the development timelines for stem cell-based medical products. Our creative engineers designed media bags (patent pending) to connect to all Cell Therapy Bioreactors - much like a computer peripheral with the ability to connect to different machines via multiple port configurations. This innovative design can save a product development team 12-15 months on custom engineering single use reagent systems for their specific expansion technologies. We are excited to further accelerate our customers’ progress towards developing lifesaving medical products that incorporate stem cell technologies.”

About RoosterBio, Inc.:
RoosterBio, Inc. is a privately held stem cell tools and technology company focused on accelerating the development of a sustainable regenerative medicine industry, one customer at a time. RoosterBio’s products are high volume, affordable, and well-characterized adult human mesenchymal stem/stromal cells (hMSCs) paired with highly engineered media systems. RoosterBio has simplified and standardized how stem cells are purchased, expanded, and used in development, leading to marked time and costs savings for customers. RoosterBio’s innovative products are ushering in a new era of productivity and standardization into the field, accelerating the road to discovery in Regenerative Medicine. For more information on RoosterBio and adult stem cells, please visit http://www.roosterbio.com, follow on twitter (@RoosterBio), or read the blog “Democratizing Cell Technologies” (http://www.roosterbio.blogspot.com). For more information, please contact Dr. Priya Baraniak at priya(at)roosterbio(dot)com.

Read the full story at http://www.prweb.com/releases/2016/12/prweb13903919.htm.


'/>"/>
Source: PRWeb
Copyright©2016 Vocus, Inc.
All rights reserved


Related biology technology :

1. Amarantus Announces cGMP Manufacturing Readiness for Its Engineered Skin Substitute (ESS) Program at Lonza Walkersville
2. Bioengineered Organ Implant Developer HART Reviews Progress and Q4 2015 Results
3. Bioengineered Organ Implant Developer HART To Host Q4 2015 Conference Call Thursday, March 17th at 5:00pm ET
4. HART Appoints Laura Mondano as Vice President of Regulatory Affairs To Lead HARTs 2016 IND Submission For its Bioengineered Organ Implant Solutions
5. Bioengineered Organ Implant Developer HART to Webcast BIO CEO Conference Presentation Tues., Feb. 9th at 8:00 am EST
6. Bioengineered Organ Implant Developer HART to Webcast Source Capital Disruptive Growth & Healthcare Conference Presentation Wed., Feb. 10th at 3:30 pm EST
7. HART and Mayo Clinic Confirm Dates for Collaborative Large-Animal Bioengineered Organ Implant Surgeries
8. Bioengineered Organ Implant Company HART to Webcast LD Micro Presentation in Los Angeles, Tues. Dec. 1st at 2:30 pm PT
9. HART Reports Significant Confirmatory Results for its 2nd Generation Bioengineered Esophagus, Trachea and Bronchus Implants
10. Tissue Engineering Pioneer Dr. Joseph P. Vacanti Agrees to Chair New Scientific Advisory Board for Bioengineered Organ Developer HART
11. Protein-Engineered Gels Mimic Bodys Own Functions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/18/2017)... ... August 18, 2017 , ... OAI, a leading Silicon Valley, ... Industries, announces the new Model 800E front and backside, semi-automatic mask aligner system. ... aligners. OAI has already received and installed several orders for the ...
(Date:8/17/2017)... CA (PRWEB) , ... August 17, 2017 , ... ... for cancer research and personalized medicine, today announced the launch of a new ... City, Missouri. The study’s goal is to evaluate the potential for early detection ...
(Date:8/16/2017)... ... August 16, 2017 , ... ... Electrospraying line of nanofiber and nanoparticle fabrication instruments from Bioinicia. ... to fully automated pilot plants and equipment for industrial manufacturing. All equipment ...
(Date:8/16/2017)... ... ... While art and science are often thought of as two completely separate modes ... Mesh Is Also a Snare, a group exhibition presented by the Philadelphia-based artist collective ... on August 17 and run through September 30. An opening reception will be held ...
Breaking Biology Technology:
(Date:4/13/2017)... According to a new market research report "Consumer IAM Market ... Authorization), Service, Authentication Type, Deployment Mode, Vertical, and Region - Global Forecast ... from USD 14.30 Billion in 2017 to USD 31.75 Billion by 2022, ... ... MarketsandMarkets Logo ...
(Date:4/11/2017)... NXT-ID, Inc. (NASDAQ:   NXTD ) ("NXT-ID" or ... independent Directors Mr. Robin D. Richards and Mr. ... the company,s corporate governance and expertise. ... Gino Pereira , Chief Executive Officer said," ... and benefiting from their considerable expertise as we move forward ...
(Date:4/5/2017)... , April 4, 2017 KEY FINDINGS ... to expand at a CAGR of 25.76% during the ... is the primary factor for the growth of the ... https://www.reportbuyer.com/product/4807905/ MARKET INSIGHTS The global stem ... technology, application, and geography. The stem cell market of ...
Breaking Biology News(10 mins):